Kennondale Capital Management »

Stoke Therapeutics shares owned by Kennondale Capital Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Kennondale Capital Management from 13F filings

Historical chart of Kennondale Capital Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Kennondale Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Kennondale Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 70k 23.50
2025-06-30 $694k 61k 11.35
2025-03-31 $280k 42k 6.65